Indivior Pharmaceuticals, Inc.
INDVNasdaqCIK 1625297HealthcareFiscal year ends Dec 31
Reports and events: 406 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2908:14 ET | 10-Q | Quarterly reportPeriod 2026-09-30 | 0001628280-26-068013 |
| 2026-10-2907:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-436953 |
| 2026-10-1516:17 ET | 8-K | 5.07 Shareholder vote results | 0001104659-26-116253 |
| 2026-10-0607:15 ET | 8-K | 8.01 Other events | 0001104659-26-113883 |
| 2026-09-1707:18 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-108417 |
| 2026-09-1516:28 ET | 8-K | 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001625297-26-000028 |
| 2026-08-1317:30 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001140361-26-032874 |
| 2026-08-0316:24 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001628280-26-051895 |
| 2026-08-0308:32 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-329618 |
| 2026-08-0306:50 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-329520 |
| 2026-08-0306:40 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-329513 |
| 2026-05-1516:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001625297-26-000024 |
| 2026-05-0407:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001625297-26-000021 |
| 2026-04-3016:02 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001628280-26-028850 |
| 2026-04-3007:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-193925 |
| 2026-03-2706:01 ET | DEF 14A | Proxy statementPeriod 2026-05-13 | 0001104659-26-035480 |
| 2026-03-1716:05 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001625297-26-000015 |
| 2026-03-1320:42 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001625297-26-000012 |
| 2026-03-1207:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001625297-26-000008 |
| 2026-02-2616:03 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001628280-26-012237 |
| 2026-02-2607:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-073363 |
| 2026-01-2607:01 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.05 Item not in the standard list; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-021660 |
| 2026-01-0807:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-006993 |
| 2025-12-3017:53 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001140361-25-046912 |
| 2025-12-2317:49 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001315863-25-000874 |
| 2025-12-2207:03 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001625297-25-000078 |
| 2025-12-1816:04 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001625297-25-000076 |
| 2025-12-1516:04 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001625297-25-000072 |
| 2025-12-1020:15 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001011438-25-000594 |
| 2025-11-2016:07 ET | 8-K | 1.02 Termination of a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001625297-25-000069 |
| 2025-11-1409:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-052210 |
| 2025-11-1321:15 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001140361-25-042045 |
| 2025-11-0520:21 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001011438-25-000504 |
| 2025-10-3016:10 ET | 8-K/A | 2.05 Exit or disposal costs | 0001625297-25-000064 |
| 2025-10-3016:09 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001628280-25-047530 |
| 2025-10-3007:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-257381 |
| 2025-10-0108:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-043293 |
| 2025-09-0516:13 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001011438-25-000461 |
| 2025-08-2607:45 ET | 8-K | 2.05 Exit or disposal costs | 0001625297-25-000059 |
| 2025-08-2216:58 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001625297-25-000056 |
| 2025-08-0416:12 ET | 8-K/A | 5.02 Departure or appointment of officers or directors | 0001628280-25-037425 |
| 2025-07-3112:59 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001625297-25-000050 |
| 2025-07-3107:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-169947 |
| 2025-07-2915:17 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001011438-25-000384 |
| 2025-07-1414:27 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001011438-25-000346 |
| 2025-06-3007:03 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001625297-25-000046 |
| 2025-06-2416:52 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001625297-25-000042 |
| 2025-06-1815:59 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001315863-25-000466 |
| 2025-06-0206:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-132699 |
| 2025-06-0218:51 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001625297-25-000035 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 08:21 ET. Listed shows no prices and gives no investment advice.